S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
DXCM · DexCom, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$80.26
-5.48
(-6.39%)
● At close: October 21 at 4:00:00 PM EDT
$80.26
+0.00
(+0.00%)
After-Hours:
5:02:13 PM EDT
DAY'S RANGE
$80.26
$79.94
$86.10
52-WEEK RANGE
$80.26
$54.11
$92.59
What's happening
- DXCM is down 6.39% today, trading at $80.26. — Live quote
- Volume today (559,278) is well below its 3-month average of 4,488,290. (Finnhub fundamentals)
- Reports earnings on 2026-10-22, 1 day away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.70 actual vs. $0.62 estimated (+12.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 15
Buy 15
Hold 5
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (35 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
DXCM
+29.55%
vs S&P 500
+17.15%
1-YEAR RETURN
DXCM
+29.10%
vs S&P 500
+13.73%
6-MONTH RETURN
DXCM
+39.71%
3-MONTH RETURN
DXCM
+13.59%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.70
Est. $0.62
BEAT +12.4%
2026-04-26 (Q1 2026)
$0.56
Est. $0.48
BEAT +17.0%
2026-01-26 (Q4 2025)
$0.56
Est. $0.48
BEAT +17.0%
2025-10-26 (Q3 2025)
$0.61
Est. $0.58
BEAT +5.3%
Valuation Measures & Ratios
Enterprise Value4$32.64B
Forward P/E529.84
PEG Ratio61.54
Price / Sales (TTM1)6.53
Price / Book79.91
EV4 / Revenue6.57
EV4 / EBITDA23.26
Profit Margin20.12%
Operating Margin22.92%
Return on Equity (ROE8)36.19%
Return on Assets (ROA9)14.85%
Avg Volume (3M)4,488,290
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $26.21B | $24.56B | $27.28B | $34.87B | $26.63B |
| P/E | 28.73 | 31.96 | 38.77 | 61.91 | 50.26 |
| Price/Sales | 5.39 | 5.35 | 6.20 | 8.32 | 6.73 |
| Price/Book | 10.00 | 8.31 | 10.01 | 13.55 | 11.75 |
| EV/Revenue | 5.16 | 5.10 | 5.79 | 8.04 | 6.50 |
| EV/EBITDA | 19.45 | 21.36 | 25.89 | — | — |
| ROE | 34.80% | 25.99% | 25.81% | 21.89% | 23.38% |
| ROA | 14.13% | 11.59% | 9.38% | 7.69% | 7.85% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short14,017,639
Change from Prior Settlement-18.80%
% of Float—
Days to Cover (Short Ratio)3.16
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 13.1% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 20.1%. Finnhub fundamentals ↗
- Trailing 52-week price return is +29.1%. Finnhub market metrics ↗
Potential concerns
- Latest SEC filing is Form 4, filed 2026-10-19; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on DXCM
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.21B | $1.16B | $1.04B | $994.2M | $1.00B | $921.0M |
| Gross profit | $830.0M | $750.3M | $731.4M | $688.8M | $589.0M | $593.8M | $626.7M | $561.9M |
| Operating income | $318.3M | $255.3M | $242.5M | $212.6M | $133.7M | $152.0M | $158.0M | $101.1M |
| Net income | $249.1M | $199.5M | $283.8M | $179.8M | $105.4M | $134.6M | $143.5M | $146.4M |
| EPS (diluted) | $0.64 | $0.51 | $0.70 | $0.45 | $0.27 | $0.34 | $0.35 | $0.36 |
| EPS (basic) | $0.65 | $0.52 | $0.73 | $0.46 | $0.27 | $0.34 | $0.36 | $0.38 |
| Operating margin | $24 | $21 | $20 | $18 | $13 | $15 | $16 | $11 |
| Net margin | $19 | $17 | $23 | $16 | $10 | $14 | $14 | $16 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B |
| Total liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B |
| Stockholders' equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B |
| Total current assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B |
| Total current liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B |
| Cash & equivalents | $1.10B | $1.12B | $917.7M | $1.84B | $1.16B | $904.9M | $606.1M | $621.2M |
| Accounts receivable | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B |
| Inventory | $726.4M | $693.6M | $629.1M | $604.1M | $570.7M | $538.2M | $542.6M | $586.3M |
| Other current assets | $37.2M | $29.7M | $29.2M | $34.5M | $46.4M | $43.3M | $29.1M | $47.6M |
| Marketable securities (non-current) | $209.5M | $219.5M | $218.0M | $216.9M | $115.8M | $115.8M | $119.3M | $46.3M |
| Property, plant & equipment | — | — | — | — | — | — | — | — |
| Goodwill | $24.1M | $24.2M | $24.2M | $24.1M | $24.1M | $23.1M | $22.8M | $23.8M |
| Intangible assets | $101.6M | $62.6M | $70.8M | $79.0M | $87.2M | $95.2M | $103.4M | $106.2M |
| Other non-current assets | $273.7M | $285.9M | $278.7M | $276.5M | $175.5M | $168.5M | $173.0M | $88.2M |
| Deferred revenue (current) | — | — | — | $2.9M | $6.1M | $7.8M | $8.0M | $13.9M |
| Other current liabilities | $9.2M | $7.6M | $7.7M | — | — | — | $8.0M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $150.8M | $141.8M | $137.1M | $147.4M | $151.6M | $150.3M | $147.9M | $129.6M |
| Retained earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B |
| Accumulated other comprehensive income (loss) | $90.0M | $106.2M | $115.0M | $81.5M | $83.6M | $2.2M | -$8.0M | $63.4M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $269.2M | $525.6M | $294.0M | $659.9M | $303.0M | $183.8M | $301.4M | $199.5M |
| Investing cash flow | $329.8M | -$298.5M | $306.6M | $192.8M | -$63.6M | $100.2M | -$303.7M | $210.3M |
| Financing cash flow | -$607.3M | -$25.0M | -$1.52B | -$175.0M | -$1.7M | $12.5M | -$1.6M | -$736.5M |
| Free cash flow | $184.5M | $449.0M | $192.1M | $579.4M | $208.9M | $96.8M | $176.8M | $88.3M |
| Capital expenditures | $84.7M | $76.6M | $101.9M | $80.5M | $94.1M | $87.0M | $124.6M | $111.2M |
| Depreciation & amortization | $68.2M | $67.1M | $191.8M | $63.6M | $63.0M | $60.0M | $165.2M | $55.3M |
| Share-based compensation | $39.0M | $43.3M | $35.0M | $45.1M | $45.3M | $34.2M | $43.3M | $43.4M |
| Deferred income taxes | -$300.0K | $300.0K | $188.0M | $118.0M | -$8.9M | -$5.8M | -$2.0M | -$11.6M |
| Change in accounts receivable | $172.1M | -$124.6M | $106.2M | -$237.8M | $184.6M | $148.9M | $7.4M | $55.6M |
| Change in inventory | $36.4M | $65.2M | $17.8M | $33.6M | $18.5M | -$6.2M | -$32.7M | $1.9M |
| Purchases of investments | $70.1M | $688.6M | $0 | $175.9M | $608.2M | $462.5M | $492.8M | $306.9M |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Other investing activities | $0 | $0 | -$100.0K | -$1.0M | $0 | $500.0K | $16.4M | -$4.0M |
| Share repurchases | $603.6M | — | $312.8M | $187.2M | $0 | — | $0 | $750.0M |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $1.8M | $35.8M | — | — | $0 | $0 | — | — |
| Other financing activities | -$1.9M | -$1.9M | -$1.9M | -$1.7M | -$1.7M | -$1.7M | -$1.6M | -$1.3M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Gross profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B |
| Operating income | $911.8M | $600.0M | $597.7M | $391.2M | $265.8M |
| Net income | $836.3M | $576.2M | $541.5M | $341.2M | $216.9M |
| EPS (diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
| EPS (basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 |
| Operating margin | $20 | $15 | $17 | $13 | $11 |
| Net margin | $18 | $14 | $15 | $12 | $9 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B |
| Total liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B |
| Stockholders' equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B |
| Total current assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B |
| Total current liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $720.8M |
| Cash & equivalents | $917.7M | $606.1M | $566.3M | $642.3M | $1.05B |
| Accounts receivable | $1.22B | $1.01B | $973.9M | $713.3M | $514.3M |
| Inventory | $629.1M | $542.6M | $559.6M | $306.7M | $357.3M |
| Other current assets | $29.2M | $29.1M | $49.3M | $26.8M | $27.4M |
| Marketable securities (non-current) | $218.0M | $119.3M | $38.5M | $19.0M | — |
| Property, plant & equipment | — | — | — | — | $801.8M |
| Goodwill | $24.2M | $22.8M | $25.2M | $25.7M | $26.5M |
| Intangible assets | $70.8M | $103.4M | $134.5M | $173.3M | $31.5M |
| Other non-current assets | $278.7M | $173.0M | $75.0M | $47.1M | $10.5M |
| Deferred revenue (current) | — | $8.0M | $18.4M | $10.1M | $2.1M |
| Other current liabilities | $7.7M | $8.0M | — | — | — |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | $137.1M | $147.9M | $125.6M | $128.3M | $90.0M |
| Retained earnings | $2.43B | $1.60B | $1.02B | $479.9M | $138.7M |
| Accumulated other comprehensive income (loss) | $115.0M | -$8.0M | -$16.7M | -$11.6M | $500.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $1.44B | $989.5M | $748.5M | $669.5M | $442.5M |
| Investing cash flow | $536.0M | -$207.5M | -$507.2M | -$521.5M | -$216.1M |
| Financing cash flow | -$1.69B | -$734.8M | -$318.6M | -$552.5M | $10.4M |
| Free cash flow | $1.08B | $630.7M | $511.9M | $304.7M | $53.3M |
| Capital expenditures | $363.5M | $358.8M | $236.6M | $364.8M | $389.2M |
| Depreciation & amortization | $251.8M | $217.7M | $186.0M | $155.9M | $102.0M |
| Share-based compensation | $159.6M | $170.4M | $150.8M | $126.5M | $113.4M |
| Deferred income taxes | $182.2M | -$43.8M | -$55.0M | -$21.6M | $15.8M |
| Change in accounts receivable | $201.9M | $35.0M | $260.1M | $199.9M | $75.5M |
| Change in inventory | $63.7M | -$12.4M | $252.6M | -$49.3M | $112.2M |
| Purchases of investments | $1.25B | $2.58B | $3.20B | $2.27B | $2.47B |
| Sales/maturities of investments | — | — | — | — | — |
| Other investing activities | -$600.0K | $15.5M | -$1.9M | -$200.0K | -$10.1M |
| Share repurchases | $500.0M | $750.0M | $688.7M | $557.7M | $0 |
| Debt issued | — | — | — | — | — |
| Debt repaid | — | — | — | — | — |
| Other financing activities | -$7.0M | -$13.0M | $1.5M | -$17.3M | -$9.9M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding DXCM as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-28 to 2026-10-15
Recent transactions
- Insiders have net sold 124,460 shares over the last 182 days, across 0 purchases and 22 sales.
- Most recent: Brown Michael Jon (EVP Chief Legal Compliance Off) — Open market sale of 1,700 shares on 2026-10-15.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)124,460 sh(22 txns)
Net Shares-124,460
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Brown Michael Jon | EVP Chief Legal Compliance Off | Open market sale | 2026-10-15 | 1,700 |
| Stern Sadie | EVP Chief People & Culture Off | Open market sale | 2026-09-28 | 2,565 |
| AUGUSTINOS NICHOLAS | Director | Open market sale | 2026-09-15 | 6,539 |
| Sylvain Jereme M | EVP, Chief Financal Officer | Open market sale | 2026-09-10 | 3,638 |
| Boehnlein Glenn S | Director | Grant / award | 2026-09-10 | 5,841 |
| Leach Jacob Steven | President, CEO, and Director | Tax withholding | 2026-08-22 | 1,451 |
| SAYER KEVIN R | Executive Chair | Open market sale | 2026-08-20 | 19,308 |
| Heller Bridgette P | Director | Open market sale | 2026-08-12 | 1,012 |
| FOLETTA MARK G | Director | Open market sale | 2026-08-03 | 2,000 |
| Coleman Jon | EVP, Chief Commercial Officer | Open market sale | 2026-06-04 | 4,911 |
| ALTMAN STEVEN R | Director | Grant / award | 2026-05-28 | 5,565 |
| Malady Kyle | Director | Grant / award | 2026-05-28 | 5,575 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-15 | Brown Michael Jon | EVP Chief Legal Compliance Off | Open market sale | 1,700 | $85.48 |
| 2026-09-28 | Stern Sadie | EVP Chief People & Culture Off | Open market sale | 2,565 | $86.15 |
| 2026-09-15 | AUGUSTINOS NICHOLAS | Director | Open market sale | 6,539 | $84.04 |
| 2026-09-15 | Brown Michael Jon | EVP Chief Legal Compliance Off | Open market sale | 1,700 | $84.04 |
| 2026-09-14 | AUGUSTINOS NICHOLAS | Director | Open market sale | 1,550 | $84.02 |
| 2026-09-10 | Sylvain Jereme M | EVP, Chief Financal Officer | Open market sale | 3,638 | $83.27 |
| 2026-09-10 | Boehnlein Glenn S | Director | Grant / award | 5,841 | $0.00 |
| 2026-08-27 | Stern Sadie | EVP Chief People & Culture Off | Open market sale | 2,565 | $88.37 |
| 2026-08-22 | Leach Jacob Steven | President, CEO, and Director | Tax withholding | 1,451 | $92.34 |
| 2026-08-22 | Sylvain Jereme M | EVP, Chief Financal Officer | Tax withholding | 1,451 | $92.34 |
| 2026-08-22 | Brown Michael Jon | EVP Chief Legal Compliance Off | Tax withholding | 1,451 | $92.34 |
| 2026-08-22 | Stern Sadie | EVP Chief People & Culture Off | Tax withholding | 1,451 | $92.34 |
| 2026-08-20 | SAYER KEVIN R | Executive Chair | Open market sale | 19,308 | $89.71 |
| 2026-08-20 | SAYER KEVIN R | Executive Chair | Open market sale | 7,351 | $90.78 |
| 2026-08-20 | SAYER KEVIN R | Executive Chair | Open market sale | 97 | $91.41 |
| 2026-08-14 | Brown Michael Jon | EVP Chief Legal Compliance Off | Open market sale | 1,700 | $91.93 |
| 2026-08-12 | AUGUSTINOS NICHOLAS | Director | Gift | 1,075 | $0.00 |
| 2026-08-12 | Heller Bridgette P | Director | Open market sale | 1,012 | $88.29 |
| 2026-08-03 | FOLETTA MARK G | Director | Open market sale | 2,000 | $85.32 |
| 2026-07-31 | FOLETTA MARK G | Director | Open market sale | 2,000 | $80.00 |
| 2026-07-20 | SAYER KEVIN R | Executive Chair | Open market sale | 26,756 | $76.32 |
| 2026-07-15 | Brown Michael Jon | EVP Chief Legal Compliance Off | Open market sale | 1,700 | $74.42 |
| 2026-07-06 | SAYER KEVIN R | Executive Chair | Open market sale | 26,756 | $72.00 |
| 2026-06-15 | Brown Michael Jon | EVP Chief Legal Compliance Off | Open market sale | 1,700 | $75.55 |
| 2026-06-15 | FOLETTA MARK G | Director | Open market sale | 3,801 | $74.10 |
| 2026-06-15 | FOLETTA MARK G | Director | Open market sale | 199 | $74.82 |
| 2026-06-04 | Coleman Jon | EVP, Chief Commercial Officer | Open market sale | 4,911 | $74.13 |
| 2026-06-03 | Coleman Jon | EVP, Chief Commercial Officer | Open market sale | 4,912 | $73.00 |
| 2026-05-28 | ALTMAN STEVEN R | Director | Grant / award | 5,565 | $0.00 |
| 2026-05-28 | Malady Kyle | Director | Grant / award | 5,575 | $0.00 |
| 2026-05-28 | AUGUSTINOS NICHOLAS | Director | Grant / award | 5,575 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 21:17 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-19 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-09-30 | 4 | 2026-09-28 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-09-14 | 8-K | 2026-09-10 | View on SEC.gov → |
| 2026-09-14 | 4 | 2026-09-10 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-10 | View on SEC.gov → |
| 2026-09-10 | 8-K | 2026-09-10 | View on SEC.gov → |
| 2026-08-28 | 4 | 2026-08-27 | View on SEC.gov → |
| 2026-08-25 | 4 | 2026-08-22 | View on SEC.gov → |
| 2026-08-25 | 4 | 2026-08-22 | View on SEC.gov → |
| 2026-08-25 | 4 | 2026-08-22 | View on SEC.gov → |
Recent news
Headlines about DXCM (DexCom, Inc.). Links open the publisher — we don’t host full articles.
-
DexCom Inc. stock underperforms Wednesday when compared to competitors
MarketWatch · 2026-10-21 -
DexCom (DXCM) Shares Fall 6.5% Amid Broader Market Gains on Octo
GuruFocus · 2026-10-21 -
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers
ChartMill · 2026-10-21 -
DexCom Slides as Investors Appear to Take Risk Off Ahead of Earnings
Quiver Quantitative · 2026-10-21 -
Dexcom schedules October 29 results for Dexcom stock
AD HOC NEWS · 2026-10-20 -
Abbott (ABT): Can Libre Keep Growing as Glucose Monitoring Becomes More Competitive?
Yahoo · 2026-10-20 -
DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study
Yahoo · 2026-10-20 -
DXCM Oct 2026 84.000 call (DXCM261030C00084000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20
No headlines in this category right now — try “All”.